Roth Capital Opens AMRN With Buy

Analysts at Roth Capital initiate coverage of Amarin Corporation plc AMRN with a “buy” rating. The target price for AMRN is set to $13. AMRN shares fell 0.46% to close at $8.59 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsHealth CarePharmaceuticalsRoth Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!